2022
DOI: 10.1016/j.jneuroim.2022.577864
|View full text |Cite
|
Sign up to set email alerts
|

Peripheral neuropathy in sarcoidosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
15
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(15 citation statements)
references
References 68 publications
0
15
0
Order By: Relevance
“…In a recent narrative review from Tavee ( 122 ), peripheral nerve involvement in sarcoidosis (SA) is distinguished in granulomatous neuropathy (GN) and the more recently described non-granulomatous small fibers neuropathy (NGSFN). The two clinical entities differ for anatomo-pathologic features and clinical presentation.…”
Section: Neuropathies In the Most Common Acquired Rheumatological Con...mentioning
confidence: 99%
“…In a recent narrative review from Tavee ( 122 ), peripheral nerve involvement in sarcoidosis (SA) is distinguished in granulomatous neuropathy (GN) and the more recently described non-granulomatous small fibers neuropathy (NGSFN). The two clinical entities differ for anatomo-pathologic features and clinical presentation.…”
Section: Neuropathies In the Most Common Acquired Rheumatological Con...mentioning
confidence: 99%
“…Immune-mediated SFN can develop in different circumstances. It can be a manifestation of an underlying systemic disease, like sarcoidosis [11 ▪ ,12 ▪ ] or Sjögren syndrome [13 ▪ ,14 ▪ ]. In addition, various auto-antibodies have been linked to SFN, in the absence of systemic diseases [15 ▪ ,16 ▪▪ ,17 ▪▪ ].…”
Section: Immune-mediated Small Fiber Neuropathymentioning
confidence: 99%
“…When immune-mediated SFN is suspected, immunotherapy seems to be the treatment of first choice. Several case reports about SFN with an underlying systemic disease showed variable positive results of treatment with intravenous immunoglobulins (IVIG), plasma exchange, high dosed steroids or biologicals [10 ▪▪ ,11 ▪ ,13 ▪ ]. However, randomized controlled trials in these patient groups are lacking.…”
Section: Immune-mediated Small Fiber Neuropathymentioning
confidence: 99%
See 1 more Smart Citation
“…Clinical presentation of neurosarcoidosis very variable. Neurologic manifestations can occur in approximately 10% of all patients with sarcoidosis, and peripheral neuropathy is presented in 5-10% of patients ( 3 - 6 ).…”
Section: Introductionmentioning
confidence: 99%